NEW YORK (GenomeWeb) – MDxHealth said today that American Pathology Partners will promote and co-market the firm's ConfirmMDx for Prostate Cancer test in the US.

American Pathology Partners is building a network of pathology labs in the US and has partnered in that effort with UniPath in Denver, Palm Beach Pathology in West Palm Beach, Fla., and Eastern Carolina Pathology in Wilson, NC. MDxHealth said the agreement extends its customer base to pathologists serving urologists in key geographic markets.

Financial and other terms of the agreement weren't disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.